STE

BioSig Technologies, Inc. (STEX) Q4 2024 Earnings

STEX·Reported December 31, 2024·Before market open

BioSig Technologies, Inc. reported Q4 2024 revenue of $13.0K. Diluted EPS came in at $-0.06, beat the $-0.36 consensus by $0.30.

Revenue
$13.0K
Diluted EPS
$-0.06beat by $0.30
Consensus: $-0.36
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet

Filings will appear here once submitted to SEC EDGAR.

Q4 2024 Earnings FAQ

Common questions about BioSig Technologies, Inc.'s Q4 2024 earnings report.

BioSig Technologies, Inc. (STEX) reported Q4 2024 earnings on December 31, 2024 before market open.

BioSig Technologies, Inc. reported revenue of $13.0K and diluted EPS of $-0.06 for Q4 2024.

EPS beat the consensus estimate of $-0.36 by $0.30.